Last reviewed · How we verify

NCT01141088

Two Bilateral Metal Stenting in Hilar Malignancy

Status unknown NA Last updated 19 December 2017
What this trial tests

NA trial testing Bilateral stent-in-stent insertion in Malignant Hilar Stricture in 80 participants. Status unknown.

Timeline
1 April 2016
Primary endpoint
30 March 2018
30 September 2018

Quick facts

Lead sponsorSoon Chun Hyang University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment80
Start date1 April 2016
Primary completion30 March 2018
Estimated completion30 September 2018
Sites2 locations across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Soon Chun Hyang University

Who can join

18 and older, any sex, with Malignant Hilar Stricture or Bilateral Stent Insertion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall median survival of nonresectable malignant hilar obstruction in most series has been less than 6 months. Most patients with malignant hilar obstruction present with advanced disease, making allative endoscopic drainage the principal therapeutic option. However, the optimal endoscopic management strategy is contentious. In malignant hilar obstruction, exclusively endoscopic placement of bilateral metal stents has been considered very difficult and complex, and it may require multiple procedures, with an increased risk of complications and mortality. To overcome this difficulty and strategize plan of management, the investigators evaluated the technical and clinical efficacy of endoscopic bilateral placement of newly designed stents, Y-configuration, followed by side-by-side insertion in failure of stent-in-stent method for the management of malignant hilar obstruction.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Prospective comparison of endoscopic bilateral stent-in-stent versus stent-by-stent deployment for inoperable advanced malignant hilar biliary stricture.
    Lee TH, Moon JH, Choi JH, Lee SH, et al · · 2019 · cited 69× · PMID 30905729 · DOI 10.1016/j.gie.2019.03.011

Verify or expand the search:

Other recruiting trials for Malignant Hilar Stricture

Currently open trials in the same condition.

Other Soon Chun Hyang University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01141088.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing